![]() |
市場調查報告書
商品編碼
1616753
產前維生素成分市場機會、成長動力、產業趨勢分析與預測 2024 - 2032Prenatal Vitamin Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032 |
2023 年,全球產前維生素原料市場價值為 7,320 萬美元。隨著人們對重要維生素重要性的認知不斷增強,人們明顯轉向更均衡的飲食。這些成分不僅透過提供必需營養素來降低生活方式障礙的風險,而且還可以增強代謝功能,從而推動市場的發展勢頭。 2022 年,世界衛生組織報告稱,全球有超過 950 萬名孕婦患有夜盲症。
預計這項統計數據將增加未來幾年對維生素 A 成分的需求。懷孕期間的營養需求激增,以滿足母親和發育中嬰兒的需求。這些成分在胎兒生長、預防貧血、確保最佳出生體重和增強孕產婦健康方面發揮關鍵作用。此外,支持產前成分消費的研發活動的加強,加上醫療專業人員的認可增加,必將擴大產品需求。
整個產業分為產品、形式、功能和區域。維生素細分市場預計將產生5,600 萬美元的收入,到2032 年複合年成長率為5.3%。促進健康骨骼發育和緩解疲勞方面的作用而得到認可。這些維生素還可以增強膳食鐵的吸收,並在預防脊柱裂等出生缺陷方面發揮至關重要的作用。隨著消費者越來越意識到維生素對細胞健康、皮膚活力和視力的好處,市場有望實現建設性成長。
市場範圍 | |
---|---|
開始年份 | 2023年 |
預測年份 | 2024-2032 |
起始值 | 7,320 萬美元 |
預測值 | 1.1515 億美元 |
複合年成長率 | 6.1% |
2023年,片劑在產前維生素原料市場中佔據37.81%的佔有率,相當於2,768萬美元。預測顯示,2024 年至 2032 年複合年成長率為 5.9%。它們為製造商和消費者提供了一種方便且經濟高效的解決方案,確保劑量準確並延長保存期限。他們在消費者中建立的信任,加上滿足特定產前需求的多樣化配方,進一步鞏固了其受歡迎程度。成長率為6.3%這種成長是由消費者對產品益處的認知提高和保健品支出的激增所推動的。此外,隨著越來越多的女性加入勞動力隊伍,對緩解懷孕期間疲勞的高性能補充劑的需求不斷增加。
The Global Prenatal Vitamin Ingredients Market was valued at USD 73.2 million in 2023. Projections indicate a growth of 6.1% CAGR from 2024 to 2032. The market expansion is largely attributed to heightened well-being concerns among pregnant women. As awareness of the importance of vital vitamins grows, there is a pronounced shift towards a more balanced diet. These ingredients not only mitigate the risk of lifestyle disorders by supplying essential nutrients but also boost metabolic functions, driving the market's momentum. In 2022, the WHO reported that over 9.5 million pregnant women globally suffered from night blindness.
This statistic is anticipated to bolster the demand for Vitamin A ingredients in the coming years. Nutritional requirements surge during pregnancy, catering to both the mother and the developing baby. These ingredients play a pivotal role in fetal growth, anemia prevention, ensuring optimal birth weight, and enhancing maternal health. Furthermore, heightened R&D activities endorsing prenatal ingredient consumption, coupled with increased endorsements from medical professionals, are set to amplify product demand.
The overall industry is segmented into product, form, function, and region. The vitamins segment is anticipated to generate USD 56 million and showcase a 5.3% CAGR through 2032. This growth is driven by the rising incorporation of vitamins D and B in prenatal formulations, recognized for their roles in promoting healthy bone development and alleviating fatigue. These vitamins also enhance dietary iron absorption and play a crucial role in preventing birth defects like spina bifida. As consumers become more aware of the benefits of vitamins for cell health, skin vitality, and eyesight, the market is poised for constructive growth.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $73.2 Million |
Forecast Value | $115.15 Million |
CAGR | 6.1% |
The tablet segment in the prenatal vitamin ingredients market commanded a 37.81% share in 2023, translating to USD 27.68 million. Projections indicate a growth rate of 5.9% CAGR from 2024 to 2032. This dominance is largely due to the widespread acceptance and user-friendliness of tablets. They present a convenient and cost-effective solution for both manufacturers and consumers, ensuring accurate dosages and prolonged shelf life. Their established trust among consumers, combined with a diverse range of formulations catering to specific prenatal needs, further cements their popularity.North America market for prenatal vitamin ingredients is set to reach USD 47.61 million, with a projected CAGR of 6.3% from 2024 to 2032. This growth is fueled by heightened consumer awareness regarding product benefits and a surge in health supplement expenditures. Additionally, as more women join the workforce, there is a rising demand for high-performance supplements that combat fatigue during pregnancy.